Physician
Spears, Michael
Spears, Michael was paid $4.89M by Medicaid between Jan 2018 and Oct 2024, across 147 billing codes. Its largest line is 87635, Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe — 14% of everything it billed.
33Billing provider infoSPEARS, MICHAEL
GREENVILLE, TX 75402
GREENVILLE, TX 75402
33aNPI1255534707assigned 06/11/2007
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$4.89M
24GClaims624,355
24DCodes billed147
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Texas
Rank by total paid#1 of 97
Median peer was paid$24K
This provider vs. median208×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 75,428 | $453K | |
| 2019 | 110,947 | $632K | |
| 2020 | 89,519 | $564K | |
| 2021 | 90,296 | $1.19M | |
| 2022 | 100,977 | $941K | |
| 2023 | 90,285 | $699K | |
| 2024incomplete | 66,903 | $407K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 14% | 18,792 | 15,955 | $671K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 9.0% | 17,438 | 14,062 | $437K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 5.7% | 5,648 | 5,242 | $279K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 5.2% | 11,290 | 10,591 | $253K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 5.2% | 11,261 | 10,571 | $253K |
| 80053 | Comprehensive metabolic panel | 4.7% | 44,316 | 33,564 | $228K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 4.4% | 3,842 | 2,834 | $216K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 4.3% | 2,666 | 2,541 | $211K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 2.9% | 595 | 553 | $144K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.9% | 49,359 | 36,195 | $142K |
| 83735 | 2.0% | 29,387 | 17,222 | $99K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.9% | 17,587 | 15,776 | $91K |
135 more codes
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.8% | 5,189 | $86K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.7% | 10,338 | $84K |
| 87040 | 1.6% | 7,044 | $80K | |
| 83690 | 1.5% | 22,394 | $75K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.5% | 17,731 | $74K |
| 82803 | 1.5% | 7,785 | $72K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.4% | 3,174 | $70K |
| 83605 | 1.1% | 10,635 | $56K | |
| 87507 | 1.1% | 325 | $52K | |
| 84484 | 1.0% | 9,961 | $51K | |
| 82962 | 1.0% | 24,140 | $50K | |
| 85027 | 1.0% | 17,151 | $49K | |
| 87480 | <1% | 3,990 | $49K | |
| 87510 | <1% | 3,988 | $49K | |
| 87430 | <1% | 5,553 | $44K | |
| 87081 | <1% | 14,254 | $42K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 2,902 | $42K |
| 87186 | <1% | 7,024 | $41K | |
| 87653 | <1% | 1,813 | $41K | |
| 83880 | <1% | 3,923 | $41K | |
| 81025 | <1% | 19,971 | $40K | |
| 87660 | <1% | 4,154 | $33K | |
| 84702 | <1% | 6,484 | $29K | |
| 80061 | Lipid panel | <1% | 7,707 | $27K |
| 84439 | <1% | 5,926 | $26K | |
| 86803 | <1% | 3,071 | $25K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 3,348 | $23K |
| 85379 | <1% | 6,175 | $23K | |
| 82607 | <1% | 3,837 | $23K | |
| 81003 | <1% | 20,817 | $22K | |
| 87340 | <1% | 3,254 | $21K | |
| 86850 | <1% | 7,428 | $21K | |
| 86140 | <1% | 8,815 | $20K | |
| 86901 | <1% | 8,535 | $19K | |
| 82746 | <1% | 2,832 | $16K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 4,764 | $15K |
| 81001 | <1% | 9,743 | $14K | |
| 86900 | <1% | 8,435 | $14K | |
| 86038 | <1% | 1,831 | $14K | |
| 82728 | <1% | 3,525 | $14K | |
| 86738 | <1% | 2,768 | $14K | |
| 86593 | <1% | 6,627 | $13K | |
| 85610 | <1% | 6,133 | $12K | |
| 82570 | <1% | 4,808 | $12K | |
| 85007 | <1% | 6,283 | $11K | |
| 80069 | <1% | 2,557 | $11K | |
| 84100 | <1% | 4,056 | $10K | |
| 87807 | <1% | 1,814 | $10K | |
| 86762 | <1% | 2,244 | $9K | |
| 83540 | <1% | 2,961 | $9K | |
| 83550 | <1% | 2,241 | $9K | |
| 85730 | <1% | 2,918 | $9K | |
| 80076 | <1% | 2,333 | $9K | |
| 84153 | <1% | 1,185 | $8K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 249 | $8K |
| 87210 | <1% | 2,747 | $6K | |
| 85652 | <1% | 4,625 | $6K | |
| 87205 | <1% | 3,056 | $6K | |
| 82950 | <1% | 2,453 | $6K | |
| 83615 | <1% | 1,751 | $5K | |
| 84145 | <1% | 819 | $5K | |
| 87641 | <1% | 218 | $4K | |
| 82043 | <1% | 2,150 | $4K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 293 | $4K |
| 82565 | <1% | 1,767 | $4K | |
| 84481 | <1% | 751 | $4K | |
| 84156 | <1% | 3,103 | $4K | |
| 82140 | <1% | 781 | $3K | |
| 84550 | <1% | 1,508 | $3K | |
| 80074 | <1% | 162 | $3K | |
| 85018 | <1% | 2,546 | $3K | |
| 82550 | <1% | 972 | $3K | |
| 83970 | <1% | 192 | $3K | |
| 82010 | <1% | 1,317 | $3K | |
| 84112 | <1% | 111 | $2K | |
| 87493 | <1% | 102 | $2K | |
| 87070 | <1% | 690 | $2K | |
| 87147 | <1% | 1,248 | $2K | |
| 86431 | <1% | 498 | $2K | |
| 88307 | <1% | 44 | $2K | |
| 80143 | <1% | 141 | $2K | |
| 86039 | <1% | 288 | $2K | |
| 86665 | <1% | 77 | $1K | |
| 80202 | <1% | 229 | $1K | |
| 87505 | <1% | 27 | $1K | |
| 85014 | <1% | 1,157 | $1K | |
| 80179 | <1% | 114 | $1K | |
| 83516 | <1% | 163 | $1K | |
| 80164 | <1% | 225 | $979.46 | |
| 86696 | <1% | 100 | $977.95 | |
| 86695 | <1% | 129 | $962.15 | |
| 85046 | <1% | 356 | $951.70 | |
| 84403 | <1% | 73 | $920.46 | |
| 84300 | <1% | 426 | $920.08 | |
| 87075 | <1% | 145 | $919.33 | |
| 83001 | <1% | 93 | $845.37 | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 12 | $816.00 |
| 87806 | <1% | 80 | $797.89 | |
| 82150 | <1% | 231 | $741.35 | |
| 85384 | <1% | 249 | $713.19 | |
| 82784 | <1% | 121 | $583.56 | |
| 82951 | <1% | 92 | $570.50 | |
| 83721 | <1% | 97 | $406.29 | |
| 86703 | <1% | 38 | $380.38 | |
| 82272 | <1% | 332 | $365.32 | |
| 86880 | <1% | 128 | $358.80 | |
| 82248 | <1% | 156 | $346.56 | |
| 86664 | <1% | 37 | $334.40 | |
| 86663 | <1% | 37 | $325.66 | |
| 86706 | <1% | 55 | $319.75 | |
| 86308 | <1% | 132 | $309.60 | |
| 84460 | <1% | 123 | $302.03 | |
| 84132 | <1% | 137 | $246.25 | |
| 82247 | <1% | 100 | $245.31 | |
| 82731 | <1% | 13 | $235.57 | |
| 81015 | <1% | 182 | $234.49 | |
| 84480 | <1% | 43 | $206.06 | |
| 87449 | <1% | 14 | $188.16 | |
| 86376 | <1% | 41 | $174.75 | |
| 82952 | <1% | 92 | $173.81 | |
| 82785 | <1% | 41 | $165.02 | |
| 82040 | <1% | 56 | $117.78 | |
| 84478 | <1% | 38 | $99.90 | |
| 82105 | <1% | 12 | $98.52 | |
| 82747 | <1% | 13 | $86.32 | |
| 81050 | <1% | 69 | $80.64 | |
| 86003 | <1% | 73 | $65.96 | |
| 80178 | <1% | 15 | $54.91 | |
| 84155 | <1% | 28 | $48.67 | |
| 82947 | <1% | 27 | $48.63 | |
| 83935 | <1% | 19 | $45.23 | |
| 83930 | <1% | 18 | $41.94 | |
| 80320 | <1% | 2,379 | $25.18 | |
| 84436 | <1% | 24 | $20.16 | |
| 0352U | 0% | 30 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.